BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22326841)

  • 1. The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    J Affect Disord; 2012 May; 138(3):295-300. PubMed ID: 22326841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype variant associated with add-on memantine in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):189-97. PubMed ID: 24103632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder.
    Lee SY; Chen SL; Wang TY; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Lu RB
    J Clin Psychopharmacol; 2017 Feb; 37(1):94-98. PubMed ID: 27930497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH2 polymorphism, associated with attenuating negative symptoms in patients with schizophrenia treated with add-on dextromethorphan.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    J Psychiatr Res; 2015 Oct; 69():50-6. PubMed ID: 26343594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    Pharmacogenet Genomics; 2010 Aug; 20(8):500-6. PubMed ID: 20577142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis.
    Yuan A; Su L; Yu S; Li C; Yu T; Sun J
    PLoS One; 2015; 10(6):e0131060. PubMed ID: 26110876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between
    Ramos-Lopez O; Mejia-Godoy R; Frías-Delgadillo KJ; Torres-Valadez R; Flores-García A; Sánchez-Enríquez S; Aguiar-García P; Martínez-López E; Zepeda-Carrillo EA
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31766642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of the DRD2/ANKK1 A1 allele in Mexican Native Amerindians and Mestizos and its association with alcohol consumption.
    Panduro A; Ramos-Lopez O; Campollo O; Zepeda-Carrillo EA; Gonzalez-Aldaco K; Torres-Valadez R; Roman S
    Drug Alcohol Depend; 2017 Mar; 172():66-72. PubMed ID: 28152448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder.
    Huang CC; Chang YH; Lee SY; Chen SL; Chen SH; Chu CH; Huang SY; Tzeng NS; Lee IH; Yeh TL; Yang YK; Lu RB
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):501-7. PubMed ID: 22514151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DRD2 and ANKK1 haplotype is associated with nicotine dependence.
    Voisey J; Swagell CD; Hughes IP; van Daal A; Noble EP; Lawford BR; Young RM; Morris CP
    Psychiatry Res; 2012 Apr; 196(2-3):285-9. PubMed ID: 22382052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
    Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
    J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DRD2/ANKK1 TaqI A1 polymorphism associates with overconsumption of unhealthy foods and biochemical abnormalities in a Mexican population.
    Rivera-Iñiguez I; Panduro A; Ramos-Lopez O; Villaseñor-Bayardo SJ; Roman S
    Eat Weight Disord; 2019 Oct; 24(5):835-844. PubMed ID: 30353454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders.
    Kibitov AA; Kiryanova EM; Salnikova LI; Bure IV; Shmukler AB; Kibitov AO
    Drug Metab Pers Ther; 2023 Jun; 38(2):133-142. PubMed ID: 36437548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
    Spellicy CJ; Kosten TR; Hamon SC; Harding MJ; Nielsen DA
    Pharmacogenet Genomics; 2013 Jul; 23(7):333-40. PubMed ID: 23635803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.